
Weight loss injections may well be to be had in Northern Ireland at the well being provider, after the primary regional weight problems control provider used to be authorized.
Currently, well being provider sufferers in Northern Ireland do not need get admission to to specialist weight control provision.
However that appears set to modify subsequent 12 months, in what the Health Minister is looking a “significant step forward”.
Mike Nesbitt’s announcement follows a public session by means of the Department of Health (DOH) at the proposed advent of the sort of provider.

The first section, which is scheduled to start in 2026, will center of attention at the construction of a community-based provider the place sufferers may have get admission to to way of life give a boost to in addition to weight problems drugs, if clinically suitable.

The division mentioned: “The service will support access to weight loss medication in line with National Institute for Health and Care Excellence guidance.
“Any rollout will likely be moderately controlled in a phased approach to be sure that remedy is equipped in a protected and efficient approach.”
They added that further phases of the service will develop, but they would be subject to funding and could include “different interventions similar to bariatric (weight reduction) surgical operation”.
‘Significant step forward’

Nesbitt said the service is a “vital step ahead”.
“Establishing a Regional Obesity Management Service may even carry us into line with different portions of the United Kingdom”.
He mentioned the provider will likely be “a phased advent and can take time and sustained funding to be absolutely established”.
“A vital day for public well being”, he concluded.
What are thin jabs?

There are two drugs on the market – semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro. Semaglutide is also used in the type 2 diabetes treatment Ozempic.
Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach.
They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).
This is an intestinal hormone which is released after eating, and typically makes people feel fuller.
Mounjaro also affects another hormone, glucose-dependent insulinotropic polypeptide (GIP), which affects metabolism and helps regulate energy balance.
Patients generally start on a low dose which is gradually increased until they reach a higher maintenance dose.
The most common side-effects are feeling sick, vomiting, bloating, constipation and diarrhoea. Some people report hair loss.
For many the side-effects are manageable and tend to go away in time; others say they stopped taking the drugs because of them.
In rare cases, serious side-effects can include gallbladder and kidney problems and depression.
Read extra about weight reduction medication and attainable unwanted effects right here.
‘It silences the noise in your head’

Marc McKee’s GP told him, aged 34, that he would be lucky to live to see his 40th birthday.
He weighed 23.4 stone, was on medication for cholesterol, blood pressure and had a fatty liver.
He told the BBC News NI podcast ‘The State of Us’ that he had struggled with his weight for his whole life.
After trying several other methods of losing weight, Marc decided to contact an online pharmacy about weight loss injections.
Since August last year he has lost 9 stone, and in the process, has come off his blood pressure medication, reduced his visceral fat levels, and his liver is back to normal.
Marc explained what the medication did for him, “It silences the noise to your head, the yearning to your head. The silence is deafening,” he mentioned.
“I do not need the obsession to devour quite a bit”.
Marc has had consultations and calls with his online pharmacy provider throughout his journey.
He has also spoken to his GP, he said he has experienced “the occasional headache after taking the medicine”.
Listen to: The State of US: “I’ve misplaced 9 stone in 9 months the usage of weight reduction jabs”